feed,title,long_url,short_url
Benzinga,"Elanco Animal Health Clocks 11% Lower Q4 Sales, FY22 Profit Guidance Below Consensus",https://benzinga.com/news/earnings/23/02/30985657/elanco-animal-health-clocks-11-lower-q4-sales-fy22-profit-guidance-below-consensus,https://da.gd/QEiPFt
Benzinga,Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients,https://benzinga.com/general/biotech/23/02/30984064/takeda-presents-vedolizumab-data-for-preventing-graft-versus-host-disease-in-stem-cell-transplant,https://da.gd/vRewK
